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Abstract Iodinated X-ray contrast media (ICM)
such as diatrizoate, iohexol, iomeprol, iopamidol,
and iopromide are commonly used in medical imaging
for radiological visualization of a variety of anatomic
structures. Because of their highly persistent nature
and poor removal by conventional wastewater treat-
ment, ICM can often remain unchanged after entering
the environment or they are transformed into many
different by-products in complex physical, chemical,
and biological processes. Large amounts of ICM and
their by-products are found in natural waters, ground-
water, drinking water (up to 100 lg/L), and even in
soil, where they can be a potential threat to the
inhabitants of these environments. Because knowl-
edge about the fate of ICM in various environments is
dispersed and it concerns specific areas, the main
purpose of this review is to summarize the available
information about their occurrence, chemical and
biological transformation/degradation, and toxicity to
living organisms. The topics discussed particularly
focus on mechanisms of ICM degradation/transfor-
mation in water using advanced oxidation processes
and the biotransformation/biodegradation of ICM by
microorganisms under different conditions, as well as
the toxicity of ICM and their transformation by-
products to humans and other organisms. Although
environmental risk is not expected from the parent
compounds of ICM, their continuous input to the water
and the formation of toxic by-products may constitute
a long-term potential risk for living organisms.
Therefore, monitoring the transport and fate of ICM
in various environments seems necessary.
Keywords Iodinated contrast media 
Transformation/biotransformation products 
Advanced oxidation processes  Iodinated disinfection
by-products  Toxicity
1 Introduction
Constantly increasing global consumption of medici-
nes by humans contributes to the systematic release of
these compounds into the environment. It was reported
that more than 600 pharmaceutical substances are
present in aquatic environments at concentrations up
to 10 lg/L (Ku¨ster and Adler 2014). As many
researchers have reported, some of these compounds
cause undesirable effects in living organisms (Huerta
et al. 2012; Deo and Halden 2013; aus der Beek et al.
2016). For this reason, in 2013, the European Parlia-
ment and the Council of the European Union placed
pharmaceuticals such as diclofenac, 17-b-estradiol,
17-a-ethinylestradiol and macrolide antibiotics:
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erythromycin, clarithromycin, azithromycin on the
Watch List of substances that should be strictly
monitored in surface waters of the EU. This was the
first document to include pharmaceutical substances
with unquestionable therapeutic activity but posing a
potential threat to the environment (Directive
2013/39/EU). The Watch List is regularly updated
and currently it also contains other pharmaceuticals
such as antibiotics: amoxicillin and ciprofloxacin. It is
also worth emphasizing that after the last revision,
diclofenac was removed from this list (Commission
Implementing Decision (EU) 2018/840).
Studies of hospital sewage composition indicate
that they can be 60% loaded with active pharmaceu-
tical compounds; these compounds are not effectively
removed by wastewater treatment plants, and there-
fore, are often present in effluents released to the
surface waters (Giannakis et al. 2017). One of the
groups of such compounds is iodinated X-ray contrast
media (ICM), which usually constitutes over 3% of all
pharmaceuticals detected in the water (Giri and Pal
2014). ICM are derivatives of 2,4,6-triiodinated ben-
zoic acid used as ionic (with a carboxylate-containing
benzene substituent) or non-ionic (without a carboxy-
late-containing benzene substituent) monomers and
dimers. The dimers consist of two triiodinated benzene
rings linked by an organic functional group. The
structure of ICM plays a dual role. Three large iodine
atoms covalently bonded to a benzene ring are in close
proximity to each other, which enhances the effective
molecular size attenuating X-rays. Additionally, the
covalent bonding of iodine atoms to a stable benzene
ring reduces the risk of the toxic effect of free iodide.
The ICM are used as positive contrast agents in
computed tomography and magnetic resonance in
venography, urography, choleography, and angiogra-
phy. They are necessary in the imaging of a variety of
anatomic structures, including solid organs like kidney
or extremities, body cavities (e.g., abdominal cavity)
or vasculature (Bottinor et al. 2013; Beckett et al.
2015). In 2016, half of the 200 million patient
examinations in Europe and the US were conducted
using contrast agents for accurate diagnoses (OECD
Health Statistics).
The constantly increasing incidence of chronic and
complex comorbidities, as well as the rising aging
population and the incidence of cancer lead to an
increase in the number of diagnostic imaging tests.
According to the market research reports prepared by
the Markets and Markets Research Private Ltd (2020)
for forecast period 2020–2024 and the Grand View
Research (2020) for 2020–2027, the size of the global
contrast media market was USD 5.23 billion in 2019
and is expected to reach USD 6.0 billion by 2024 and
USD 6.9 billion by 2027. In 2019, iodinated contrast
agents accounted for the largest market share of 67.2%
Table 1 Recommended doses and physicochemical properties of selected ICM (pubchem.ncbi.nlm.nih.gov and drugbank.ca)
Doses/properties Diatrizoate Iomeprol Iopromide Iohexol Iopamidol
Dose, g 0.236–118
(Bayer Inc.)
0.11–139
(Bracco UK Ltd)
2.0–158
(Bayer Inc.)
2.5–130
(GE Healthcare Inc.)
7.5–170
(Bracco UK Ltd.)
Molecular mass, g/mol 613.916 777.089 791.116 821.142 777.089
Log P 3.30 - 1.80 - 2.05 - 3.05 - 2.42
Solubility, mg/mL 0.107 0.155 0.092 0.796 0.117
Melting point, C 261–262 198–203 145–149 174–180 300
Charge Ionic Non-ionic Non-ionic Non-ionic Non-ionic
Osmolality High Low Low Low Low
Topological polar surface area, A˚2 95.5 180 169 200 188
Polarizability, A˚2 38.43 55.19 57.65 60.37 55.67
pKa (strongest acid) 2.17 5.65 4.23 11.73 4.15
pKa (strongest base) - 4.2 2.53 2.19 - 3 1.42
The doses given are recommended for adults by manufacturers. The dose range depends on the type of medical examination. logP—
the logarithm of the ratio of the concentrations of a solute between the two solvents; pKa—an acid dissociation constant, P—the
octanol/water partition coefficient
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in North America and 25.1% in Europe. Despite the
lack of such data for Asia, the Asia Pacific market
(Japan, China, India, Korea and other) is expected to
register the highest growth during the forecast period
from 2020 to 2024.
Nowadays, the most commonly used ICM are ionic
diatrizoate (3,5-diacetamido-2,4,6-triiodobenzoic
acid) and non-ionic iohexol (5-[N-(2,3-
dihydroxypropyl)acetamido]-2,4,6-triiodo-N,N0-bis(2,
3-dihydroxypropyl)isophthalamide), iomeprol (N,N0-
bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(N-methylgly-
colamido) isophthalamide), iopamidol (N,N0-bis[2-hy-
droxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-5 lactami-
doisophthalamide) and iopromide (N,N0-Bis(2,3-dihy-
droxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N-
methylisophthalamide). Diatrizoate was first approved
Fig. 1 Proposed transformation pathways of diatrizoate treated
with AOPs (black arrows), during water disinfection (green
arrows) and in the presence of microorganisms (blue arrows)
(Jeong et al. 2010; Velo-Gala et al. 2012; Hapeshi et al. 2013;
Rastogi et al. 2014; Del Moro et al. 2015; Radjenovic and
Petrovic 2016; Zhou et al. 2017). (Color figure online)
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for medical purposes in the US in 1954. It is a high-
osmolality contrast agent (1550 mOsm/kg) and hyper-
tonic to blood; therefore, its intravascular administration
is reduced due to the risk of adverse reactions.
Nowadays, diatrizoate is reserved for direct pyelogra-
phy, cholangiography, cystography, and ureothrography
(Thomsen and Dorph 1993; Andreucci et al. 2014). The
development of non-ionic, low-osmolar ICMhas greatly
reduced the incidence of adverse reactions to contrast
media. A good example is iomeprol, a non-ionic contrast
agent of the latest generation released by BraccoUKLtd
in 1995. In contrast to iohexol, it has lower chemotox-
icity, osmolality (730 mOsm/kg), and viscosity and
higher water solubility. Moreover, iomeprol solutions
are chemically stable and do not contain chelating
agents (e.g., EDTA), which can cause adverse haemo-
dynamic and electrophysiological effects (Dooley and
Jarvis 2000). Similar to iomeprol, iopamidol is highly
soluble in water, with very low toxicity; therefore, it is
used as a safe intrathecal contrast medium in pediatrics
(Wells et al. 1988; Aime et al. 2005). In turn, low-
osmolar, non-ionic iopromide is a water-soluble X-ray
contrast agent for intravascular administration (Mruk
2016). The average doses of the appropriate ICM for
adults vary and depend on the patient’s body weight and
the type of examination. For example, according to the
Bracco UK Ltd recommendations, the dose of iomeprol
(trade name—Iomeron 400) ranges from 0.11 g for
urography to 139 g for computed tomography and
angiocardiography. Recommended doses and the
physicochemical properties of the five ICM discussed
above are presented in Table 1.
The stable structure of ICM is a main reason for
their recalcitrance and high persistence, leading to
their accumulation in the environment. They are
present in surface water and groundwater at concen-
trations ranging from ng/L to lg/L (Sacher et al.
2001). However, only iopromide was recognized by
the Globally Harmonized System of Classification and
Fig. 2 Proposed transformation pathways of iohexol treated with AOPs (black arrows) and in the presence of microorganisms (blue
arrows) (Jeong et al. 2010; Kormos et al. 2010; Hapeshi et al. 2013; Giannakis et al. 2017). (Color figure online)
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Labelling of Chemicals (GHS) as an environmental
hazard identified by the code H410, meaning that it is
very toxic to aquatic life with long-lasting effects. The
identification and quantification of ICM and their
transformation products is a big challenge, especially
when they are present in only trace amounts.
Table 2 Transformation efficiency of selected ICM depending on their concentration and the physicochemical environmental
conditions
Initial ICM conc., mg/L Treatment Reagents Transformation efficiency, % References
Diatrizoate
288.7 c Irradiation OH, e- aq 40 Jeong et al. (2010)
25 c Irradiation OH, e- aq, H
 91.9 Velo-Gala et al. (2012)
12.7 Electrolysis Na2SO4
NaNO3
79
86
Radjenovic and Petrovic (2016)
63.59 Electrolysis OH [ 90 Bocos et al. (2016)
70 Electrolysis NaClO4,
Na2SO4
[ 85
[ 80
Del Moro et al. (2015)
30 UV radiation SO4
- 84 Zhou et al. (2017)
0.1 Chlorination NH2Cl, ClO2, NaClO 0 Wendel et al. (2014)
Iohexol
328–410 c Irradiation OH,
e- aq
79 ± 6
81 ± 16
Jeong et al. (2010)
8.2–821 UV radiation H2O2, Fe
2? [ 90 Giannakis et al. (2017)
0.1 Chlorination NH2Cl, ClO2, NaClO 0 Wendel et al. (2014)
Iopromide
316–396 c irradiation OH,
e- aq
71
87
Jeong et al. (2010)
15.8 Electrolysis Na2SO4
NaNO3
46
75
Radjenovic and Petrovic (2016)
70 Electrolysis NaClO4, Na2SO4 [ 85
[ 80
Del Moro et al. (2015)
0.1 Chlorination NH2Cl, ClO2, NaClO 0 Wendel et al. (2014)
Iopamidol
311–389 c Irradiation OH,
e- aq
73
75
Jeong et al. (2010)
70 Electrolysis NaClO4
Na2SO4
[ 85
[ 80
Del Moro et al. (2015)
7.8 UV radiation Fe2(C2O4)3, H2O2 95 Zhao et al. (2014)
0.1 Chlorination NH2Cl
ClO2
NaClO
7.9
0
42–100
Wendel et al. (2014)
Iomeprol
1–389 c Irradiation OH,
e- aq
68
78
Jeong et al. (2010)
70 Electrolysis NaClO4
Na2SO4
[ 85
[ 80
Del Moro et al. (2015)
0.1 Chlorination NH2Cl, ClO2, NaClO 0 Wendel et al. (2014)
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Table 3 Biotransformation efficiency of selected ICM depending on their concentration and the physicochemical and biological
environmental conditions
Initial ICM
conc., mg/L
Material Conditions Biotransformation
efficiency, %
References
Diatrizoate
0.2 Activated sludge Aerobic, MBBR 0 Casas et al.
(2015)
10 Soil, groundwater Anaerobic/aerobic [ 95 Redeker et al.
(2014)
10 Urban wastewater Aerobic, MBBR 73 Hapeshi et al.
(2013)
10–35 Activated sludge, river
water and sediment
Anaerobic/aerobic 0–95 Kalsch (1999)
1000 Soil and river sediment Anaerobic/aerobic 0 Kormos et al.
(2010)
1860 Activated sludge Aerobic 100 Haib and
Ku¨mmerer
(2006)
Iohexol
0.2 Activated sludge Aerobic, MBBR 60–80 Casas et al.
(2015)
10 Urban wastewater Aerobic, MBBR 79 Hapeshi et al.
(2013)
1000 Soil and river sediment Aerobic [ 95 Kormos et al.
(2010)
Iopromide
0.2 Activated sludge Aerobic, MBBR 0 Casas et al.
(2015)
12 Trametes versicolor,
synthetic sewage
Aerobic 65.4 Gros et al.
(2014)
45 Activated sludge, river
water and sediment
Anaerobic/aerobic 85–95 Kalsch (1999)
30 Sewage with Pseudomonas
sp. I-24
Starch as additional carbon source,
anaerobic-anoxic/aerobic
61.3–95 Liu et al. (2013)
30 Pseudomonas sp. I-24 Liquid batch culture, starch as additional
carbon source
88.24 Xu et al. (2014)
1000 Soil and groundwater Aerobic [ 90 Shulz et al.
(2008)
1000 Nitrifying activated sludge Aerobic 61 Batt et al. (2006)
Iopamidol
0.2 Activated sludge Aerobic, MBBR 60–80 Casas et al.
(2015)
1000 Soil and river sediment Aerobic 50
[ 95
Kormos et al.
(2010)
Iomeprol
0.2 Activated sludge Aerobic, MBBR 60–80 Casas et al.
(2015)
200 P. fluorescens AR 11 Anoxic/ aerobic, batch culture, static
column, flow-through microcosm
10–42 Hack et al.
(2015)
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Identification and quantification therefore require
advanced sensitive analytical methods such as high-
performance liquid chromatography with tandem
mass spectrometry (HPLC/MS) and ion chromatogra-
phy. Monitoring the occurrence and fate of ICM is
necessary because their continuous input to surface
and groundwater, even at low concentrations, may
constitute a long-term potential risk for living organ-
isms. Because of scarce information about the impact
of ICM on ecosystems concerning chronic toxicity,
Table 3 continued
Initial ICM
conc., mg/L
Material Conditions Biotransformation
efficiency, %
References
1000 Soil and river sediment Aerobic [ 95 Kormos et al.
(2010)
MBBR moving bed biofilm reactor
Fig. 3 Proposed transformation pathways of iomeprol treated with AOPs (black arrows), during water disinfection (green arrows) and
in the presence of microorganisms (blue arrows) (Jeong et al. 2010; Kormos et al. 2010; Del Moro et al. 2015). (Color figure online)
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more studies are needed in order to prevent possible
future threats.
This review summarizes current knowledge about
(1) (bio)transformation of ICM in wastewater, water,
sediments, and soil, (2) formed by-products that are
dependent on physicochemical and environmental
conditions, and (3) the toxicity of ICM and their by-
products to living organisms.
2 Transformation of ICM
A single dose of ICM during the examination of a
patient is up to 200 g (Wendel et al. 2014; Matsushita
et al. 2015). After the test, the compounds are excreted
unchanged from the body within 24 h and discharged
into wastewater. Because of their complex chemical
structure, ICM can remain unchanged or they can be
transformed in a conventional wastewater treatment
plant (WWTP) into various products through physical,
chemical or biological processes, which are discussed
in the following subsections of this chapter. Conse-
quently, the unchanged ICM and their by-products can
enter surface water, groundwater, and even in drinking
water at concentrations up to 100 lg/L (Duirk et al.
2011; Wendel et al. 2014). It was reported that
iohexol, iomeprol, iopamidol, and iopromide in
wastewater, river water, groundwater and drinking
water generated approximately 46 different ICM
transformation products (TPs), which were detected
mainly during biological treatment of wastes (Kormos
et al. 2011). Among them, iopamidol proved to be the
most persistent in wastewater, with a transformation
efficiency of 35%, whereas iohexol, iomeprol, and
Fig. 4 Proposed transformation pathways of iopamidol treated
with AOPs (black arrows), during water disinfection (green
arrows) and in the presence of microorganisms (blue arrows)
(Jeong et al. 2010; Kormos et al. 2010; Wendel et al. 2014; Zhao
et al. 2014; Del Moro et al. 2015). (Color figure online)
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iopromide were less stable, and they were eliminated
with efficiencies of 85–90%. In total, 26 TPs were
detected in WWTP effluents. Furthermore, iomeprol
generated the highest concentration of TPs, in the
range of 120 ng/L (TP 701) to 500 ng/L (TP 687),
which were measured during bank filtration and
granular activated carbon filtration at a drinking water
treatment plant, although the concentration of
iomeprol alone was very low, about 11 ng/L (Kormos
et al. 2011).
2.1 Advanced oxidation processes in ICM
degradation
Numerous physical and chemical treatments like
membrane filtration, coagulation, flotation, electroly-
sis, and ozonation have been introduced into WWTPs
Fig. 5 Proposed transformation pathways of iopromide treated with AOPs (black arrows) and in the presence of microorganisms (blue
arrows) (Schulz et al. 2008; Jeong et al. 2010; Del Moro et al. 2015; Radjenovic and Petrovic 2016). (Color figure online)
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to handle a wide spectrum of wastes. Among them,
advanced oxidation processes (AOPs) utilising reac-
tive species involving hydroxyl (OH) or sulphate
(SO4
-) radicals are considered to be the most
effective methods for destroying the structure of
ICM (Ikehata et al. 2006; Giannakis et al. 2017).
Although AOPs have an obvious advantage in elim-
inating ICM over biological methods, they are not
commonly used in conventional sewage treatment
plants (Oliva et al. 2018). It should be emphasized that
to date the overwhelming majority of experiments
have been carried out under laboratory conditions
using synthetic media, which does not reflect the real
conditions in sewage treatment plants. One of the main
reasons for this is high cost of this procedure on an
industrial scale (Dewil et al. 2017). Another reason is
the lack of applicable regulations regarding the need to
monitor the concentration and fate of ICM and their
by-products during the wastewater treatment process.
In the presence of the reactive radicals, both ionic
and non-ionic ICM are deiodinated and their side
chains are transformed through similar reactions.
However, their degradation efficiencies are different
and depend on the experimental conditions (Table 2).
In water solutions of ionic diatrizoate treated by c-
irradiation (Jeong et al. 2010; Velo-Gala et al. 2012),
Fenton’s reagents, iron(III), iron(II) salts and UV
radiation (Velo-Gala et al. 2014; Bocos et al. 2016),
the main dehalogenation reaction in plausible degra-
dation pathways is an ipso attack of OH on the iodine
site. As a result, the iodine is substituted by the
addition of a hydroxyl group and finally 3,5-diac-
etamide-2,4,6-trihydroxybenzoic acid (TP 284)
(Fig. 1) is formed. Furthermore, diatrizoate or its
deiodinated derivatives can undergo a deacetylation
reaction to form amine derivatives [3,5-diamino-
2,4,6-trihydroxybenzoic acid (TP 200) or 3,5-di-
amino-2,4,6-triiodinebenzoic acid (TP 527)]. Another
plausible reaction is oxidative decarboxylation via
OH, thus giving a phenolic product (Fig. 1). Further
ring cleavage leads to the formation of short-chain
carboxylic acids (Bocos et al. 2016).
Iohexol is another model non-ionic ICM that has
been subjected to extensive investigation using AOPs,
including UV, UV/H2O2, UV/H2O2/Fe
2? treatment
and c-irradiation (Jeong et al. 2010; Giannakis et al.
2017). Based on the identified intermediates of iohexol
degradation, several parallel reactions are postulated
to obtain more polar by-products. The ipso attack of
OH at the iodo site with further oxidation by this
radical results in the formation of deiodinated products
and dissociative electron attachment, yielding a deio-
dinated product and OH, giving a phenolic compound.
In further steps, amine or ketone products are
produced after decarboxylation and hydrogen abstrac-
tion from side chains, respectively (Fig. 2) (Jeong et al.
2010; Giannakis et al. 2017). Other non-ionic ICM
such as iopromide, iopamidol or iomeprol are
degraded through reactions similar to those of iohexol.
Literature shows, that the transformation of iopromide
and iopamidol treated by AOPs generates the forma-
tion of about 30 different TPs, whereas during the
transformation of iomeprol, about 20 TPs are formed
(Fig. 3) (Schulz et al. 2008; Jeong et al. 2010; Kormos
et al. 2010; Wendel et al. 2014; Zhao et al. 2014; Del
Moro et al. 2015; Radjenovic and Petrovic 2016). In
one of the proposed transformation pathways, the one
side chain of iomeprol is reduced to an amide, whereas
the easiest form of iopamidol contains two side chains,
which are transformed to amides (Fig. 4). The shortest
identified side chains of iopromide are hydroxyl or
amine groups (Fig. 5).
2.2 Effect of water disinfection on ICM
transformation
Because ICM are not effectively removed during
wastewater treatment, they are released into water,
becoming an additional source of iodine in reservoirs
of drinking water. Because even low concentrations of
ICM can generate undesired by-products during the
disinfection of raw water, the fate of iodine released
during ICM deiodination is crucial. In addition to the
most-often detected disinfection by-products (DBPs)
such as chloroform, dichloroacetonitrile, trichloroa-
cetic acid, and dichloroacetic acid, different iodinated
disinfection by-products (I-DBPs) in the presence of
iodine could be formed. One of the most undesirable
groups of I-DBPs during ICM oxidation in water are
iodo-trihalomethanes (I-THMs), which impart a nasty
odour and taste to drinking water. Their organoleptic
threshold concentration in water can be as much as
0.03 lg/L (Bichsel and von Gunten 2000). During the
first step of disinfecting raw water, iodine in the
presence of chlorine or chloramine is quickly oxidized
to hypoiodous acid (HOI), which reacts with organic
matter to produce the I-THMs (especially CHI3). The
formation of CHI3 during oxidative drinking water
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treatment is influenced by the physicochemical
parameters of the treated water, such as temperature,
pH, iodine concentration, type and concentration of
organic matter and the stability of the oxidant (Bichsel
and von Gunten 2000). Research by Ye et al. (2014)
indicated that the formation of I-THMs during chlo-
rination and chloramination of raw water containing
iopamidol, iopromide, iodixanol, iohexol, and diatri-
zoate collected from the intake of the Yangshupu
drinking water treatment plant (Shanghai, China)
depended on the presence and concentration of
chlorine and monochloramine. The chloramination
of water generated more mixed I-THMs than chlori-
nation. For example, after the addition of NH2Cl at
concentrations of 200 and 250 lM into water
containing iopamidol, six different I-THMs (CHI3,
CHBrI2, CHClI2, CHBr2I, CHBrClI, CHCl2I) were
identified, whereas in the presence of Cl2 at the same
concentrations only three I-THMs (CHClI2, CHCl2I,
CHBrClI) were detected. The highest total concentra-
tions of I-THMs in chlorinated and chloraminated
water were 276 and 254 nM, respectively. The
concentrations of I-THMs formed during chlorination
and chloramination of water containing the other ICM
were significantly lower. In the chlorinated water, the
concentrations did not exceed 100 nM, whereas in the
chloraminated water, it was about 200 nM. Depending
on the increase in the concentrations of I-THMs
detected during water chlorination and chloramina-
tion, the ICM tested can be ordered as follows:
iopamidol[ iohexol[ iodixanol[ diatrizoate[
iopromide and iopamidol[ diatrizoate[ iodixanol[
iohexol[ iopromide.
In addition to classifying the I-THMs as small
chlorinated DBPs, stable chlorinated DBPs with
higher molecular weights and containing benzene
rings can also appear during the disinfection of water.
Interestingly, the formation of I-THMs is not corre-
lated with the total formation of I-DBPs (Allard et al.
2016). Iopromide photodecomposition followed by
chlorination or chloramination indicated a decrease in
the amount of I-DBPs in the presence of HOCl in the
concentration range of 1–5 mg Cl2/L. In turn, iodine
incorporation into I-THMs increased in the presence
of 2 mg Cl2/L and decreased in the presence of 5 mg
Cl2/L (CHCl3 dominated in the mixture of THMs).
The presence of NH2Cl in the concentration range of
1–5 mg Cl2/L did not influence the amount of the
I-DBPs, but it caused an increase in the concentrations
of the I-THMs (mainly CHI3). In the presence of
aqueous chlorine, five different reactions during
transformation of the I-DBPs were observed: cleavage
of side chains or their inversion, exchange of iodine by
chlorine, amide hydrolysis and oxidation of amine to a
nitro group (Wendel et al. 2014, 2016). During the
disinfection of water containing iopamidol, five dif-
ferent high-molecular weight I-DBPs with molecular
masses of 778, 705, 735, 643 and 551 Da were
identified (Fig. 4) (Wendel et al. 2014, 2016). I-DBP
705 appeared after deacylation of one side chain of
iopamidol; however, I-DBP 735 was identified after
the oxidation of an amine to a nitro group in the rest of
this side chain. I-DBP 643 and I-DBP 551 were
formed after replacing iodine with chlorine, followed
by the oxidation of –NH2 to –NO2
- in I-DBP 705.
I-DBP 778 was a product of inversion of the side chain
followed by amide hydrolysis. It should also be
pointed that the oxidative-coupling reactions between
primary amines like DBP 705 could also lead to the
formation of dimers (DBP 1406) (Wendel et al. 2014).
In total, about 20 different high-molecular weight
I-DBPs were identified during the transformation of
iopamidol (Fig. 3). Interestingly, the efficiency of the
transformation (0.1 mg/L) in the presence of
hypochlorite, monochloramine and chlorine dioxide
(3 mg/L) ranged from 0% (in the presence of ClO2)
through 8% (with NH2Cl, pH 8.5) to 100% (with
NaClO, pH 8.5). However, the transformation of
diatrizoate, iohexol, iopromide and iomeprol under the
same conditions was not observed (Table 2).
2.3 Biotransformation of ICM
Despite many studies, the biological transformation/
degradation of ICM is still poorly understood and
described in the literature. Among bacteria, only two
strains, Pseudomonas sp. I-24 and Pseudomonas
fluorescens AR11, were reported as iopromide- and
iomeprol-degraders, respectively (Liu et al. 2013; Xu
et al. 2014; Hack et al. 2015). Pseudomonas sp. I-24
was isolated from the activated sludge of a wastewater
treatment plant in Shanghai, and it was able to co-
metabolize iopromide (Liu et al. 2013). Interestingly,
an inoculation of this bacterium into wastewater
contaminated with iopromide (15 lg/L) significantly
enhanced the removal efficiency of ICM from 29.8%
in the control wastewater to 61.3% in the bioaug-
mented wastewater. Although Pseudomonas sp. I-24
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has been identified as capable of degrading iopromide,
the pathway of its biodegradation, including interme-
diates and the enzymes involved in the transformation
of the formed compounds, has not been described yet.
The second bacterial strain, P. fluorescens AR11,
which is capable of degrading iomeprol, did not
originate from a source in contact with ICM, it was
isolated from raw milk during cheese production
(Hack et al. 2015). It was able to remove iomeprol
(390 mg/L) from a nutrient solution mixed with sand
in batch experiments under aerobic and anoxic con-
ditions with maximum efficiencies of 42% and 10%,
respectively, within 30 days. However, despite the
high concentration of TPs in the culture, it was found
that the iomeprol was not completely degraded by this
bacterium. Similar to Pseudomonas sp. I-24, the
forming TPs and enzymes engaged in iomeprol
degradation by P. fluorescens AR11, as well as the
complete degradation pathways, remain unknown.
The second group of microorganisms that are
recognized to be capable of transforming ICM is
white rot fungi. The fungi are able to oxidize a variety
of organic contaminants due to secretion of extracel-
lular ligninolytic enzymes. The non-specificity of free
radical-mediated lignin peroxidases, manganese-de-
pendent peroxidases and laccases enable fungi to
transform a large number of haloaromatic compounds
(Hatakka and Hammel 2011; Rodrı´guez-Couto 2017).
One of the potential degraders of diatrizoate and
iopromide is Trametes versicolor, a common species
found throughout the world. A study by Rode and
Mu¨ller (1998) clearly indicated that the initial trans-
formation and partial deiodination of diatrizoate (614
mg/L) by T. versicolor in batch cultures were catal-
ysed by fungal extracellular peroxidases and laccases.
The metabolites of these transformations (i.e., TP
506—Fig. 1) at concentrations corresponding to half
the diatrizoate disappearance were determined and
identified after 14 days. The authors suggested that in
addition to the reductive diiodination, an additional
process may occur, such as polymerization of inter-
mediate metabolites to forms that can not be detected
by HPLC. In another study, Gros et al. (2014) revealed
that the efficiency of iopromide removal by T.
versicolor reached 65.4% (0.4 mg/L) in hospital
wastewater and 62% (12 mg/L) in liquid synthetic
medium within 5 and 7 days, respectively. Addition-
ally, the identification of eight different transformation
products may indicate that they were formed through
sequential deiodination (TP 665, 539, 413) and
N-dealkylation of the amide at the hydroxylated side
chain of the molecule (TP 451) (Fig. 5).
Nowadays, special attention is focusing on the
biodegradation of ICM by a mixed population of
microorganisms present in activated sludge, soil, river
sediment and groundwater, where ICM concentrations
reach values from 0.2 to 1860 mg/L (Table 3). It is
well known that an individual microorganism can
generally metabolize only a limited range of sub-
strates. The biodegradation/biotransformation of
many recalcitrant pollutants is easier when more than
a single species cooperates with each other. A defined
consortia of microorganisms equipped with broad
enzymatic capacities usually increases the rate and
extent of contaminant biodegradation/biotransforma-
tion. Some members of the microbial community have
the ability to secrete important degradative enzymes
and growth factors, whereas others can increase their
solubility or bioavailability. Therefore, mixed bacte-
rial and fungal populations can degrade pollutants
more effectively and in shorter times than single
microbial strains. From a practical point of view, the
cooperation of fungal–bacterial co-cultures degrade
aromatic xenobiotics by breaking ring structures using
fungal extracellular ligninolytic enzymes and further
metabolism of the formed intermediates by bacteria
(Mikeskova´ et al. 2012; Sheng et al. 2017). This
phenomenon has been observed during biodegradation
of polycyclic aromatic hydrocarbons (Boonchan et al.
2000; Machı´n-Ramı´rez et al. 2010), polychlorinated
biphenyls (Ferna´ndez-Sa´nchez et al. 2001) and azo
dyes (Gou et al. 2009). In the literature concerning the
biodegradability of ICM, the particular microbial
groups or species in mixed consortia engaged in this
process are not identified and characterized (Kormos
et al. 2010; Zhang et al. 2016). Information in this field
is still therefore very limited and refers only to the
participation of nitrifying bacteria in enhancing ICM
removal from activated sludge (Batt et al. 2006;
Torresi et al. 2016). For example, Batt et al. (2006)
reported that the efficiency of iopromide removal
(0.10–0.27 lg/L) in nitrifying activated sludge
reached 61%, whereas in conventional activated
sludge, it was negligible.
In addition to the microbial activity, the biotrans-
formation efficiency of ICM also depends on abiotic
factors, such as the structure, concentration and
properties of the biotransformed compound, as well
123
348 Rev Environ Sci Biotechnol (2020) 19:337–354
as the physicochemical conditions of the environmen-
tal matrices. A comparison of the biodegradability of
diatrizoate and iohexol, which differ significantly in
structure and properties (Table 1), in a moving bed
biofilm reactor (MBBR) clearly indicated that diatri-
zoate was less susceptible to degradation than iohexol.
The efficiency of diatrizoate (10 mg/L) transformation
within 5 days was 50%, whereas iohexol was
biotransformed under the same conditions with an
efficiency of 70%. Although the efficiencies of
biotransformation were different, the number of
formed intermediates was similar (13–14 TPs). For
this reason, it could be expected that TPs form through
several competing pathways, mainly through hydrox-
ylation, deacetylation, deiodination, deamination and
fully dehalogenated main end product (Figs. 1, 2)
(Hapeshi et al. 2013). A comparison of the biodegrad-
ability of diatrizoate and iopromide in river water plus
sediment also showed that ionic diatrizoate was hardly
biotransformed but the non-ionic iopromide was
transformed (Kalsch 1999) (Table 3). Under the same
conditions, diatrizoate (35 mg/L) and iopromide (45
mg/L) were biotransformed with an efficiency of 90%
over 50 days and 50 h, respectively. Nevertheless,
mineralization of the tested ICM to carbon dioxide
was not observed. The weaker biodegradability of
diatrizoate compared to ionic ICM could be explained
by the steric hindrance between the large iodine atoms
and the remaining short side chains of this compound.
Some published data have indicated that the
biodegradability of ionic iohexol, iomeprol and
iopamidol might also differ (Kormos et al. 2010;
Casas et al. 2015). Experiments in aerobic soil–water
and river sediment–water batch systems implied that
iohexol and iomeprol were more effectively biotrans-
formed in comparison with iopamidol (Kormos et al.
2010). Under experimental conditions, more than 90%
of the initial concentrations of iohexol and iomeprol
were biotransformed within 49 days, whereas similar
iopamidol loss occurred within 100 days (Table 3).
The numbers of intermediates formed were also
different. During the biotransformation of iohexol
(Fig. 2), iomeprol (Fig. 3), and iopamidol (Fig. 4), 15,
11, and eight TPs were detected, respectively.
According to the researchers conducted (Kormos
et al. 2010), three types of biochemical reactions can
biotransform ICM. The first is oxidation of the primary
or secondary alcohol groups catalysed by alcohol and
aldehyde dehydrogenases, whereas the second is
decarboxylation by thiamine pyrophosphate-depen-
dent enzymes, like transketolases, a-keto acid decar-
boxylases or puryvate-like decarboxylases. The last
one is cleavage of the C–N bond by monooxygenases,
alcohol, and aldehyde dehydrogenases or decarboxy-
lases. The activity of similar enzymes was also
suggested by Schulz et al. (2008) during a study on
iopromide biotransformation in water–soil systems.
However, many attempts to isolate and identify
enzymes involved in microbial metabolism of ICM
have failed. To date, knowledge of the proposed
pathways of ICM biotransformation are incomplete
and enzymes are not accurately characterized. The
type of enzymes and their participation in subsequent
stages of biotransformation are mainly proposed based
on the structures of the identified TPs, the time
sequence of their appearance and fundamental meta-
bolic knowledge.
Physicochemical environmental conditions also
affect the biotransformation of ICM. The most
important factors are considered to be the availability
of oxygen, organic carbon, and photochemical pre-
treatment. The importance of oxygen during diatri-
zoate (10 mg/L) biotransformation in anaerobic soil–
water batch systems was indicated by Redeker et al.
(2014), who reported that diatrizoate was successively
deiodinated and deacetylated through seven identified
TPs to 3,5-diaminobenzoic acid as a stable final
product. Further biotransformation of this compound
was only observed under aerobic conditions. The
important role of the availability of dissolved organic
carbon in the biotransformation of ICMwas confirmed
in a model of transport of iomeprol during stream–
groundwater interactions (Engelhardt et al. 2014). The
transformation of this ICM and its daughter products
were simulated as a cometabolic process during
organic carbon degradation, the main driver for spatial
and temporal changes in redox zonation. Photochem-
ical pre-treatment of polluted wastewater is also
needed to enhance the elimination of ICM. An
example was the treatment of hospital wastewater
containing diatrizoate and iohexol (1 mg/L) by UV
irradiation combined with TiO2, which resulted in
disruption of the chemical structure of ICM and
enabled their further transformation using biological
processes (Borowska et al. 2015). The removal
efficiencies of diatrizoate and iohexol from sewage
without photochemical pre-treatment were 38% and
60%, respectively, whereas more than 90% of
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diatrizoate and the complete removal of iohexol were
recorded after the combined photochemical and bio-
logical treatment of wastes.
3 Toxicity of ICM and their transformation by-
products
Despite the fact that contrast agents are regarded as
safe pharmaceuticals, their use in disease diagnosis is
not completely risk free for humans. They can cause
adverse reactions in patients from mild symptoms to
severe, life-threatening reactions. The adverse reac-
tions are classified as acute and late. Acute adverse
reactions occur within one hour after injection and
they are five times more common after the adminis-
tration of ionic, monomeric, high-osmolar agents than
with low-osmolar agents. The symptoms include
injection site pain, nausea, vomiting, urticaria, pruri-
tus, or bronchospasm. The late adverse reactions ([ 1
h to 7 days) are mainly manifested with skin reactions
as a pruritic maculopapular rash or urticaria after
exposure to the non-ionic iso-osmolar dimer.
Hypotension and cardiovascular shock are the less
common delayed reactions. The renal adverse reaction
to contrast media is contrast-induced nephropathy.
The incidence of this reaction is less than 5% in
patients with normal renal function; however, it can be
as much as 50% in those with preexisting renal
dysfunction (Thomsen 2011; Pasternak and Wil-
liamson 2012; Bottinor et al. 2013). In current
practice, low-osmolar non-ionic ICM are used most
often for intravascular injections due to less toxicity
and fewer side effects than ionic agents. Adverse
reactions are observed in approximately 15% and 3%
of patients after the use of high-(ionic) and low-
osmolality (non-ionic) agents, respectively (Pasternak
and Williamson 2012). There are three main factors
responsible for the higher toxicity of ionic ICM
compared to non-ionic agents: (1) hyperosmolality
(osmolality 5–8 times higher than blood), (2) the
weakest ability to attenuate X-rays; therefore, they
need to be administered in higher concentrations than
non-ionic ICM and (3) charged molecules tend to
disrupt the electrical potential of cell membranes
(Pasternak and Williamson 2012).
The continuous input and persistence of ICM even
at trace levels in the environment can have a negative
impact on the ecosystem; however, the results of
environmental risk assessment of ICM are not con-
clusive. Although parent compounds as diatrizoate
(Polo et al. 2016), iopromide (Steger-Hartmann et al.
1999), iopamidol and iohexol (Matsushita et al. 2015)
are considered to be non-toxic, the results of in silico
model predictions and toxicity tests of their by-
products are ambiguous. The photolytic transforma-
tion products of diatrizoic acid, which has a molecular
mass 351 (Fig. 1), were predicted to be mutagenic
according to Leadscope’s Salmonella and chromo-
some aberration models, as well as genotoxic accord-
ing to a micronucleus in vivo model (Rastogi et al.
2014). Simultaneously, the experimental data of a
bioluminescence inhibition test of Vibrio fischeri
indicated that photodegradation products of diatri-
zoate (25 mg/L) were more toxic than the parent
compound. The tested photodegradation products
included 2 TPs formed during treatment of diatrizoate
by solar radiation (SR) in the presence of H2O2, 1 TP
using SR/K2S2O8 and 2 TPs using an SR/Fenton
reaction. The authors indicated that the inhibition of
bacterial bioluminescence was proportional to the
diatrizoate depletion and by-product formation under
all tested conditions (Polo et al. 2016). However, none
of the 14 TPs from the microbial transformation of
diatrizoate (20 mg/L) was toxic to Daphnia magna
(Hapeshi et al. 2013). The differences in toxicity of
TPs formed during photodegradation and microbial
transformation may result from the different chemical
structures of the photodegradation products in com-
parison with biotransformation intermediates (Fig. 1).
It was reported that the chlorination of ICM-
containing solutions can also lead to the formation of
toxic and mutagenic compounds. The 96-h chlorina-
tion of an iopamidol solution (1 mg/L) induced the
formation of three mutagenic disinfection DBPs with
molecular weights of 578, 643 and 719, respectively
(Fig. 4). An Ames assay with Salmonella typhimurium
TA98 and S. typhimurium TA100 indicated that these
DBPs induced frameshift mutations rather than base-
pair-substitution mutations (Matsushita et al. 2015).
Additionally, a mammalian (Chinese hamster ovary)
cell chronic cytotoxicity assay confirmed that the
chlorination of iopamidol (1 g/L) generated a mixture
of cytotoxic DBPs. Median lethal concentration
(LC50) of the residual DBPs mixture was 332 ng/lL
(Wendel et al. 2014). More detailed studies with five
isolated iopamidol chlorination DBPs allowed
researchers to distinguish between two of the most
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cytotoxic DBPs, with respective molecular weights of
551 and 735 (Fig. 3). The LC50 values calculated for
DBP 551 and DBP 735 were 0.6 and 0.7 g/L,
respectively (Wendel et al. 2016). The formation of
toxic I-DBPs also occurred after the chlorination and
chloramination of photodecomposed moieties of
iopromide (8 mg/L). An in vitro toxicity test con-
ducted by Allard et al. (2016) with the AREc32 cell-
line with an ARE reporter plasmid coupled to reporter
gene encoding luciferase and the redox cycling
compound tert-butylhydroquinone (tBHQ) (model
inducing agent of ARE-enhanced gene expression)
showed that water chloramination with NH2Cl (5 mg
Cl2/L) generated more toxic I-DBPs than chlorination
with HOCl (5 mg Cl2/L). The calculated equivalent
concentration (tBHQ-EQ) for non-treated iopromide
increased from 4. 29 to 20.60 lg/L for irradiated
iopromide (UV254 4000 J/m
2) and 55.27 lg/L for
chloraminated iopromide. It was also proved that the
addition of organic matter led to the formation of an
increasing number of toxic I-DBPs through an
increase in the number of reactive sites available for
reaction with chlorinated oxidants. Although environ-
mental risk is not expected from the parent compounds
of ICM, the toxicological effects associated with the
metabolites are confirmed.
4 Conclusions
Although ICM are regarded as safe pharmaceuticals
and their use is unquestioned in the diagnosis of
diseases, there is a real risk of negative impact of their
transformation by-products on the functioning of
various ecosystems. In order to prevent a potential
threat caused by their presence in the environment,
new effective physicochemical and biological meth-
ods for their removal should be developed, and more
attention should be paid to the transport and fate of
parent ICM in the environment. Biological approaches
are widely regarded as more economical and environ-
ment friendly than physicochemical methods, but their
development requires very thorough knowledge about
the mechanisms and pathways of ICM degradation.
One of the possible future solutions may be the
construction of a defined consortia of bacteria and
fungi capable of degrading or complementing each
other in breaking down individual ICM. Unfortu-
nately, knowledge of the proposed pathways of ICM
biotransformation/biodegradation is still incomplete
and the enzymes engaged in these processes have not
been identified. Speculations about their activity based
on the identified intermediates are important, but they
are insufficient to develop a comprehensive and safe
method of biological removal of ICM. Therefore,
research in this field should be continued and inten-
sified to expand our knowledge about the still poorly
understood microbial degradation of ICM.
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